ClinTex CTi CTI Price

What is ClinTex CTi (CTI)?

Revolutionizing Medicine Development: ClinTex CTI's Blockchain-Based Clinical Trials Intelligence

In the fast-paced world of pharmaceuticals, where every breakthrough can mean a life-changing discovery, ClinTex CTI emerges as a game-changer with its revolutionary platform, Clinical Trials Intelligence (CTi). Powered by blockchain technology, predictive analytics, machine learning, and smart contracts, ClinTex aims to transform the landscape of medicine development, making clinical trials faster, more efficient, and cost-effective.

The Vision of ClinTex CTI

Founded in 2018 by Brendan Mannion and Neill Barron, ClinTex set out with a vision to bring down the cost of medicine and accelerate the speed at which new drugs reach those in need. The culmination of their efforts resulted in the creation of CTi, a scalable blockchain platform designed to be the single source of truth for the clinical trial and pharmaceutical industry.

How ClinTex Works

At the core of CTi is a decentralized ledger that securely stores the entire history of key clinical trial metrics in an immutable manner. This data serves as the foundation for custom predictive analytics algorithms that drive ongoing trials on the platform. The use of blockchain ensures end-to-end auditable workflow management, with all preventive and corrective actions documented on the Clinical Trials Intelligence blockchain.

The CTi Ecosystem

CTi comprises seven distinct applications, each delivering invaluable insights to different stakeholders in the clinical trial process. From Clinical Project Managers to Site Monitors, these applications, including CTI-OEM for Operational Excellence, CTI-CDV for Clinical Data Visualizations, and CTI-PDA for Predictive Analytics, work in harmony to enhance the quality and efficiency of clinical trials.

Key Features of CTi Applications:

CTI-OEM (Operational Excellence): Provides intuitive oversight for clinical trials, enabling real-time decision-making.

CTI-CDV (Clinical Data Visualizations): Enhances clinical data review through data visualizations, ensuring trial integrity and patient safety.

CTI-PDA (Predictive Analytics): Forecasts issues and events by combining operational and clinical data sources, allowing proactive action.

CTI-RBM (Risk Based Monitoring): Uses historical data to predict risks, reducing site monitoring costs during a clinical trial.

CTAI (Artificial Intelligence): Empowers trial professionals to interact with data through a natural language processing engine.

CTI-PRR (Patient Recruitment and Retention): Manages patient recruitment and retention through predictive alerts.

CTI-SIM (Site Investigators): Manages the recruitment of investigators for clinical trials and token payment compensation.

Milestones and Future Goals

ClinTex has made significant strides since its inception, with the launch of the CTi-OEM MVP in Q3 2021 and the migration of CTi clinical data statistical summaries on-chain in Q2 2022. The project has its sights set on streamlining analytics development, supporting a Phase III clinical trial, and deploying the technology in live chronic pain clinical trials in 2023.

ClinTex CTI stands at the forefront of innovation in the pharmaceutical industry, leveraging blockchain and advanced analytics to redefine how clinical trials are conducted. As the platform continues to evolve and achieve its goals, the potential for faster, more cost-effective medicine development becomes a reality, ultimately benefiting those who depend on breakthroughs in healthcare.

What is unique about ClinTex CTi (CTI)?

ClinTex CTI (CTi) stands out for revolutionizing medicine development through its blockchain-based Clinical Trials Intelligence platform, integrating predictive analytics, machine learning, and smart contracts to streamline clinical trials, reduce costs, and expedite new drug availability.

Who are the founders of ClinTex CTi (CTI)?

ClinTex CTI (CTi) was founded by pharmaceutical and data analytics experts Brendan Mannion and Neill Barron in 2018, bringing a wealth of expertise to the mission of transforming the pharmaceutical industry.